My Application Form Status

Check the status of your application form with Angel Broking.
Arq - The Hyper Intelligent Investment Engine By Angel Broking
State Bank of India to hold AGM
May 29,2017

State Bank of India announced that the th Annual General Meeting(AGM) of the bank on 27 June 2017.

Powered by Capital Market - Live News

Dull debut for PSP Projects
May 29,2017

Meanwhile, the S&P BSE Sensex was up 25.41 points or 0.08% at 31,053.62. The S&P BSE Small-Cap index was down 147.50 points or 0.98% at 14,938.76.

The stock debuted at Rs 199, a discount of 5.24% from its initial public offer (IPO) price. So far the stock hit a high of Rs 208.95 and low of Rs 189.05. On BSE, so far 1.68 lakh shares were traded on the counter.

The IPO of PSP Projects received bids for 4.75 crore shares compared with 55.44 lakh shares on offer, as per NSE data. The IPO was subscribed 8.58 times. The price band for the IPO was fixed at Rs 205-210 per share. The issue opened on 17 May 2017 and closed on 19 May 2017.

The qualified institutional buyers (QIBs) category was subscribed 8.38 times. The non institutional investors category was subscribed 10.39 times. The retail individual investors (RIIs) category was subscribed 6.47 times.

The IPO committee of PSP Projects at a meeting held on 16 May 2017 allocated 45.36 lakh shares to nine anchor investors at Rs 210 per share aggregating to Rs 95.25 crore.

PSP Projects had reported net profit of Rs 21.48 crore on net sales of Rs 239.10 crore in nine months ended 31 December 2016.

PSP Projects is a multidisciplinary company developing industrial, institutional, government, government residential and residential projects in India. Services offered are across the construction value chain, ranging from planning and design to construction and post-construction activities to private and public sector enterprises.

Powered by Capital Market - Live News

Board of Weizmann recommends final dividend
May 29,2017

Weizmann announced that the Board of Directors of the Company at its meeting held on 24 May 2017, inter alia, have recommended the final dividend of Rs 0.5 per equity Share (i.e. 5%) , subject to the approval of the shareholders.

Powered by Capital Market - Live News

Board of Weizmann Forex recommends final dividend
May 29,2017

Weizmann Forex announced that the Board of Directors of the Company at its meeting held on 24 May 2017, inter alia, have recommended the final dividend of Rs 3 per equity Share (i.e. 30%) , subject to the approval of the shareholders.

Powered by Capital Market - Live News

Board of TVS Srichakra recommends final dividend
May 29,2017

TVS Srichakra announced that the Board of Directors of the Company at its meeting held on 24 May 2017, inter alia, have recommended the final dividend of Rs 50.7 per equity Share (i.e. 507%) , subject to the approval of the shareholders.

Powered by Capital Market - Live News

Board of Tata Investment Corporation recommends final dividend
May 29,2017

Tata Investment Corporation announced that the Board of Directors of the Company at its meeting held on 24 May 2017, inter alia, have recommended the final dividend of Rs 18 per equity Share (i.e. 180%) , subject to the approval of the shareholders.

Powered by Capital Market - Live News

Mahanagar Gas sizzles after good Q4 performance
May 29,2017

The result was announced after market hours on Friday, 26 May 2017.

Meanwhile, the S&P BSE Sensex was up 24.87 points or 0.08% at 31,053.08. The S&P BSE Mid-Cap index was down 107.57 points or 0.74% at 14,412.33.

On the BSE, 16,000 shares were traded on the counter so far as against the average daily volumes of 19,929 shares in the past one quarter. The stock had hit a high of Rs 988 and a low of Rs 966 so far during the day. The stock had hit a record high of Rs 1053.20 on 28 April 2017 and a record low of Rs 493.20 on 13 July 2016.

The stock had underperformed the market over the past one month till 26 May 2017, sliding 6.01% compared with 2.97% rise in the Sensex. The scrip, however, outperformed the market in past one quarter, gaining 10.77% as against Sensexs 7.39% gains.

The mid-cap company has equity capital of Rs 98.78 crore. Face value per share is Rs 10.

Mahanagar Gas said that the board of directors of the company has recommended a final dividend of Rs 11 per equity share for the financial year ended 31 March 2017.

Mahanagar Gas (MGL) is one of Indias leading natural gas distribution companies. MGL is a joint venture between GAIL (India) and BGAPH (a subsidiary of Royal Dutch Shell Plc).

Powered by Capital Market - Live News

FDC advances after reporting decent Q4 earnings
May 29,2017

The result was announced after market hours on Friday, 26 May 2017.

Meanwhile, the S&P BSE Sensex was down 8.19 points, or 0.03% at 31,020.02.The S&P BSE Mid-Cap Index was down 158.88 points, or 1.09% at 14,361.02.

On the BSE, 9,026 shares were traded on the counter so far as against the average daily volumes of 4.63 lakh shares in the past on quarter. The stock had hit a high of Rs 184.40 and a low of Rs 178 so far during the day.

The stock had hit a 52-week high of Rs 240 on 10 November 2016 and a 52-week low of Rs 165.50 on 24 June 2016. The stock had underperformed the market over the past one month till 26 May 2017, declining 9.91% compared with the Sensexs 2.97% rise. The scrip had also underperformed the market over the past one quarter declining 16.95% as against the Sensexs 7.39% rise.

The mid-cap company has equity capital of Rs 17.78 crore. Face value per share is Rs 1.

FDCs board of directors recommended a dividend of Rs 2.25 per equity share for the year ended March 2017.

FDC is a pharmaceutical company. The company is engaged in manufacture of specialized formulations, and oral rehydration salts (ORS).

Powered by Capital Market - Live News

Sun Pharma tanks after posting dismal Q4 results
May 29,2017

The result was announced after market hours on Friday, 26 May 2017.

The stock has skidded 23.49% in seven sessions to its ruling price of Rs 500.25, from a close of Rs 653.90 on 18 May 2017.

Meanwhile, the S&P BSE Sensex was almost unchanged at 31,027.26.

Spurt in volume was witnessed on the counter. On the BSE, 27.24 lakh shares were traded on the counter so far as against the average daily volumes of 3.89 lakh shares in the past one quarter. The stock had hit a low of Rs 493 so far during the day, its lowest level since 28 August 2013. The stock had hit a high of Rs 532.80 in intraday trade.

The stock had hit a 52-week high of Rs 854.50 on 5 August 2016. The stock had underperformed the market over the past one month till 26 May 2017, sliding 11.53% compared with 2.97% rise in the Sensex. The scrip had also underperformed the market in past one quarter, declining 15.82% as against Sensexs 7.39% gains.

The large-cap company has equity capital of Rs 239.93 crore. Face value per share is Rs 1.

Sun Pharmaceutical Industries board of directors recommended dividend of Rs 3.5 per share for the year ended 31 March 2017 (FY 2017).

India sales rose 10% at Rs 1916 crore in Q4 March 2017 over Q4 March 2016. Other operating income for the quarter stood at Rs 312 crore which includes a milestone payment from Almirall S.A (Spain) as part of the licensing agreement for the development and commercialization of Tildrakizumab for psoriasis in Europe.

Dilip Shanghvi, Managing Director of the company said that Q4 performance reflects the impact of the challenging generic pricing environment in the US. Despite this, the company continued to invest strong cash flows in enhancing specialty pipeline.

In Q4, the company announced the acceptance of Tildrakizumab filing by EMA for European markets and for US market in May 2017. The company will be gradually filing Tildrakizumab in all key markets in the next few quarters. The company recently had a pre-new drug application (NDA) meeting with the United States Food & Drug Administration (USFDA) for Seciera and the company is on track to file this NDA by Q3 December 2017. The company continues to evaluate filing Seciera in other markets.

During the quarter, the USFDA lifted the import alert on the Mohali facility while remediation efforts are on-going to bring back the Halol facility into full cGMP compliance, he added.

Sun Pharma is a specialty generic pharmaceutical company and Indias top pharmaceutical company.

Powered by Capital Market - Live News

Board of Alkem Laboratories recommends final dividend
May 29,2017

Alkem Laboratories announced that the Board of Directors of the Company at its meeting held on 26 May 2017, inter alia, have recommended the final dividend of Rs 9 per equity Share (i.e. 450%) , subject to the approval of the shareholders.

Powered by Capital Market - Live News

Board of 63 Moons Techs. recommends final dividend
May 29,2017

63 Moons Techs. announced that the Board of Directors of the Company at its meeting held on 26 May 2017, inter alia, have recommended the final dividend of Rs 2 per equity Share (i.e. 100%) , subject to the approval of the shareholders.

Powered by Capital Market - Live News

Board of Simmonds Marshall recommends final dividend
May 29,2017

Simmonds Marshall announced that the Board of Directors of the Company at its meeting held on 25 May 2017, inter alia, have recommended the final dividend of Rs 0.5 per equity Share (i.e. 25%) , subject to the approval of the shareholders.

Powered by Capital Market - Live News

Board of PC Jeweller recommends final dividend
May 29,2017

PC Jeweller announced that the Board of Directors of the Company at its meeting held on 25 May 2017, inter alia, have recommended the final dividend of Rs 1 per equity Share (i.e. 10%) , subject to the approval of the shareholders.

Powered by Capital Market - Live News

Board of Salzer Electronics recommends final dividend
May 29,2017

Salzer Electronics announced that the Board of Directors of the Company at its meeting held on 25 May 2017, inter alia, have recommended the final dividend of Rs 1.6 per equity Share (i.e. 16%) , subject to the approval of the shareholders.

Powered by Capital Market - Live News

Board of Shreyas Shipping & Logistics recommends final dividend
May 29,2017

Shreyas Shipping & Logistics announced that the Board of Directors of the Company at its meeting held on 25 May 2017, inter alia, have recommended the final dividend of Rs 1 per equity Share (i.e. 10%) , subject to the approval of the shareholders.

Powered by Capital Market - Live News